The transdifferentiation of peripheral blood progenitor cells and amniotic stem cells into a neural lineage as a potential treatment for spinal cord injury

Summary

The transdifferentiation of peripheral blood progenitor cells and amniotic stem cells into a neural lineage as a potential treatment for spinal cord injury is a master's thesis^[1].

Key Facts

• The transdifferentiation of peripheral blood progenitor cells and amniotic stem cells into a neural lineage as a potential treatment for spinal cord injury authored Gary D'Souza^[2].
• The transdifferentiation of peripheral blood progenitor cells and amniotic stem cells into a neural lineage as a potential treatment for spinal cord injury's instance of is recorded as master's thesis^[3].
• The transdifferentiation of peripheral blood progenitor cells and amniotic stem cells into a neural lineage as a potential treatment for spinal cord injury's publisher is recorded as ResearchSpace@Auckland^[4].
• The transdifferentiation of peripheral blood progenitor cells and amniotic stem cells into a neural lineage as a potential treatment for spinal cord injury's country of origin is recorded as New Zealand^[5].
• The transdifferentiation of peripheral blood progenitor cells and amniotic stem cells into a neural lineage as a potential treatment for spinal cord injury's publication date is recorded as +2010-00-00T00:00:00Z^[6].
• The transdifferentiation of peripheral blood progenitor cells and amniotic stem cells into a neural lineage as a potential treatment for spinal cord injury's main subject is recorded as molecular medicine^[7].
• The transdifferentiation of peripheral blood progenitor cells and amniotic stem cells into a neural lineage as a potential treatment for spinal cord injury's main subject is recorded as pathology^[8].
• The transdifferentiation of peripheral blood progenitor cells and amniotic stem cells into a neural lineage as a potential treatment for spinal cord injury's Handle ID is recorded as 2292/6649^[9].
• The transdifferentiation of peripheral blood progenitor cells and amniotic stem cells into a neural lineage as a potential treatment for spinal cord injury's title is recorded as The transdifferentiation of peripheral blood progenitor cells and amniotic stem cells into a neural lineage as a potential treatment for spinal cord injury^[10].
• The transdifferentiation of peripheral blood progenitor cells and amniotic stem cells into a neural lineage as a potential treatment for spinal cord injury's copyright holder is recorded as Gary D'Souza^[11].
• The transdifferentiation of peripheral blood progenitor cells and amniotic stem cells into a neural lineage as a potential treatment for spinal cord injury's thesis submitted to is recorded as University of Auckland^[12].
• The transdifferentiation of peripheral blood progenitor cells and amniotic stem cells into a neural lineage as a potential treatment for spinal cord injury's on focus list of Wikimedia project is recorded as NZThesisProject^[13].
• The transdifferentiation of peripheral blood progenitor cells and amniotic stem cells into a neural lineage as a potential treatment for spinal cord injury's copyright status is recorded as copyrighted^[14].
• The transdifferentiation of peripheral blood progenitor cells and amniotic stem cells into a neural lineage as a potential treatment for spinal cord injury's online access status is recorded as closed user group^[15].
• The transdifferentiation of peripheral blood progenitor cells and amniotic stem cells into a neural lineage as a potential treatment for spinal cord injury's thesis committee member is recorded as Geoffrey Krissansen^[16].

Body

Designation and Status

The transdifferentiation of peripheral blood progenitor cells and amniotic stem cells into a neural lineage as a potential treatment for spinal cord injury's instance of is recorded as master's thesis^[3].